Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. May 16, 2014; 6(5): 156-167
Published online May 16, 2014. doi: 10.4253/wjge.v6.i5.156
Gastrointestinal endoscopy in the pregnant woman
David Friedel, Stavros Stavropoulos, Shahzad Iqbal, Mitchell S Cappell
David Friedel, Stavros Stavropoulos, Shahzad Iqbal, Division of Gastroenterology, Winthrop Medical Center, Mineola, NY 11501, United States
Mitchell S Cappell, Division of Gastroenterology and Hepatology, William Beaumont Hospital, Royal Oak, MI 48073, United States
Mitchell S Cappell, Oakland University Wiliiam Beaumont School of Medicine, Royal Oak, MI 48073, United States
Author contributions: Friedel D and Cappell MS contributed equally to this manuscript; all the authors contributed to the writing and approved the final version.
Correspondence to: Mitchell S Cappell, MD, PhD, Division of Gastroenterology and Hepatology, William Beaumont Hospital, 3535 West Thirteen Mile Road, Royal Oak, MI 48073, United States. mscappell@yahoo.com
Telephone: +1-248-5511227 Fax: +1-248-5517581
Received: November 15, 2013
Revised: February 18, 2014
Accepted: April 16, 2014
Published online: May 16, 2014
Processing time: 186 Days and 4.6 Hours
Abstract

About 20000 gastrointestinal endoscopies are performed annually in America in pregnant women. Gastrointestinal endoscopy during pregnancy raises the critical issue of fetal safety in addition to patient safety. Endoscopic medications may be potentially abortifacient or teratogenic. Generally, Food and Drug Administration category B or C drugs should be used for endoscopy. Esophagogastroduodenoscopy (EGD) seems to be relatively safe for both mother and fetus based on two retrospective studies of 83 and 60 pregnant patients. The diagnostic yield is about 95% when EGD is performed for gastrointestinal bleeding. EGD indications during pregnancy include acute gastrointestinal bleeding, dysphagia > 1 wk, or endoscopic therapy. Therapeutic EGD is experimental due to scant data, but should be strongly considered for urgent indications such as active bleeding. One study of 48 sigmoidoscopies performed during pregnancy showed relatively favorable fetal outcomes, rare bad fetal outcomes, and bad outcomes linked to very sick mothers. Sigmoidoscopy should be strongly considered for strong indications, including significant acute lower gastrointestinal bleeding, chronic diarrhea, distal colonic stricture, suspected inflammatory bowel disease flare, and potential colonic malignancy. Data on colonoscopy during pregnancy are limited. One study of 20 pregnant patients showed rare poor fetal outcomes. Colonoscopy is generally experimental during pregnancy, but can be considered for strong indications: known colonic mass/stricture, active lower gastrointestinal bleeding, or colonoscopic therapy. Endoscopic retrograde cholangiopancreatography (ERCP) entails fetal risks from fetal radiation exposure. ERCP risks to mother and fetus appear to be acceptable when performed for ERCP therapy, as demonstrated by analysis of nearly 350 cases during pregnancy. Justifiable indications include symptomatic or complicated choledocholithiasis, manifested by jaundice, cholangitis, gallstone pancreatitis, or dilated choledochus. ERCP should be performed by an expert endoscopist, with informed consent about fetal radiation risks, minimizing fetal radiation exposure, and using an attending anesthesiologist. Endoscopy is likely most safe during the second trimester of pregnancy.

Keywords: Gastrointestinal endoscopy; Esophagogastroduodenoscopy; Flexible sigmoidoscopy; Colonoscopy; Endoscopic retrograde cholangiopancreatography; Teratogenicity; Endoscopic indications; Endoscopy safety; Endoscopic complications; Pregnancy

Core tip: This article critically analysis the literature on the safety of gastrointestinal endoscopy during pregnancy. Endoscopy is frequently indicated during pregnancy with about 20000 endoscopies performed during pregnancy per annum in America. Although gastrointestinal endoscopy is generally safe in the non-pregnant population the safety of the fetus as well as the patient must be analyzed for endoscopy during pregnancy. This study reviews the literature on the safety of esophagogastroduodenoscopy, endoscopic retrograde cholangiopancreatography, flexible sigmoidoscopy, and colonoscopy during pregnancy and provides guidelines about the indications, safety precautions, and efficacy of endoscopy during pregnancy.